Role of SIRT6 in calcific aortic valve disease

  • Miller, Jordan D, (PI)

Project: Research project

Description

DESCRIPTION (provided by applicant): Aging is associated with progressive increases in cardiovascular calcification1. Hemodynamically significant aortic valve stenosis affects 3% of the population over age 65. Patients with even moderate aortic valve stenosis (peak velocity of 3-4 m/sec) have a 5 year event-free survival of less than 40%, with the only approved treatment being valve replacement surgery. Recent work, however, described the presence of osteoblast-like cells, osteoclast-like cells, and bone matrix in calcified aortic valves, which suggests that valve calcification is an active, potentially modifiable process. Preliminary data from our group suggest that there are substantial epigenetic modifications present in cells from calcified aortic valves. Specifically, expression of sirtuin 6 is markedly reduced in stenotic valves and strongly associated with increases in protein and histone acetylation. Experimentally, global deletion of SIRT6 in mice results in a dramatic progeroid phenotype, and patients with progeroid syndromes have a much greater propensity for development of cardiovascular calcification. As many risk factors for valve calcification are associated with increases in oxidative stress, we also sought to determine whether there is a link between increases in oxidative stress and histone acetylation/sirtuin activity. Thus, the aims of the current application is to experimentall determine whether: 1) increases in oxidative stress increase histone acetylation and accelerate progression of aortic valve calcification and stenosis, 2) altering SIRT6 levels accelerates or slows progression of aortic valve stenosis in hypercholesterolemic mice, and 3) deletion of SIRT6 in vascular endothelium or neural crest-derived cells (i.e., cells that form the aortic valve
and outflow tract) accelerate progression of CAVS. We will use a combination of novel in vivo animal models and in vitro methods to identify mechanisms whereby oxidative stress and SIRT6 impact osteoblast/osteoblast-like cell differentiation and activity in aortic valves. By using thes approaches to identify mechanisms that slow the progression of calcific aortic valve disease, we hope to identify therapies that will improve both the lifespan and health span of humans.
StatusFinished
Effective start/end date1/4/1311/30/17

Funding

  • National Institutes of Health: $391,537.00
  • National Institutes of Health: $397,500.00
  • National Institutes of Health: $397,500.00
  • National Institutes of Health: $389,550.00

Fingerprint

Aortic Diseases
Aortic Valve Stenosis
Aortic Valve
Oxidative Stress
Acetylation
Osteoblasts
Histones
Bone Matrix
Neural Crest
Vascular Endothelium
Osteoclasts
Epigenomics
Disease-Free Survival
Cell Differentiation
Animal Models
Phenotype
Health
Therapeutics
Population
Proteins

ASJC

  • Medicine(all)